Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,676,614,716
-$607,266,062 QoQ
Shares Held
10,539,098
-21.6% QoQ
Ownership
0.437%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#32
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 75%
Shared 22%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $6,486,971,678 across 12 Drug Manufacturers - General names. JNJ ranks #1 (41.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
10,539,098 | $2,676,614,716 | |
| 2 | PFE |
Pfizer Inc
|
56,551,011 | $1,361,748,341 | |
| 3 | ABBV |
AbbVie Inc.
|
4,388,338 | $1,104,281,370 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,651,833 | $840,392,576 | |
| 5 | LLY |
ELI LILLY & Co
|
145,790 | $174,864,912 | |
| 6 | BIIB |
Biogen Inc.
|
744,892 | $160,941,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
948,427 | $54,648,359 | |
| 8 | NVS |
Novartis AG
|
293,443 | $45,988,386 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,676,614,716 | 10,539,098 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $3,283,880,778 | 13,434,302 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,391,613,729 | 16,388,566 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,256,225,884 | 17,561,352 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,750,355,855 | 18,005,603 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,031,954,870 | 18,282,410 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,579,116,054 | 17,833,744 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,012,607,235 | 18,589,456 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,744,979,069 | 18,780,645 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,681,145,537 | 16,948,894 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,649,422,141 | 16,903,293 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $2,743,847,281 | 17,616,997 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,444,426,008 | 20,809,727 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,270,064,605 | 21,097,191 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,735,397,969 | 21,145,757 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,719,223,651 | 22,767,040 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,180,997,935 | 23,553,591 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,706,750,098 | 26,557,299 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,584,301,011 | 26,797,808 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,363,110,645 | 27,016,165 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,509,128,518 | 27,371,182 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,579,563,276 | 27,864,699 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,448,902,506 | 28,268,538 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $4,384,440,066 | 29,449,490 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,161,284,446 | 29,590,304 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $3,872,896,484 | 29,534,786 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||